hexaminolevulinate hydrochloride
hexaminolevulinate hydrochloride is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: injection, powder, lyophilized, for solution.
Drug Details
- Generic Name
- hexaminolevulinate hydrochloride
- Brand Names
- N/A
- Application Number
- Sponsor
- Patheon Italia S.p.A.
- NDC Codes
- 1
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- N/A
- Active Ingredients
- HEXAMINOLEVULINATE HYDROCHLORIDE
Indications and Usage
1 INDICATIONS AND USAGE CYSVIEW is indicated for the cystoscopic detection of carcinoma of the bladder, including carcinoma in situ (CIS), in adult patients: With suspected or known lesion(s) based on a prior cystoscopy Undergoing surveillance cystoscopy for bladder cancer Limitations of Use CYSVIEW is not a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer [see Warnings and Precautions (5.2) ] . CYSVIEW is an optical imaging agent indicated for the cystoscopic detection of carcinoma of the bladder, including carcinoma in situ (CIS), in adult patients: With suspected or known lesion(s) on the basis of a prior cystoscopy Undergoing surveillance cystoscopy for bladder cancer Limitations of Use CYSVIEW is not a replacement for random bladder biopsies or other procedures used in the detection of bladder cancer. ( 1 , 5.2 )